Short-term complications of open reduction and internal fixation of olecranon fractures: a national database study

鹰嘴骨折切开复位内固定术的短期并发症:一项全国数据库研究

阅读:1

Abstract

BACKGROUND: Olecranon fractures comprise ∼10% of upper extremity fractures, often managed with open reduction and internal fixation (ORIF). Despite generally favorable outcomes, short-term complications remain challenging and uncharacterized. This retrospective study aims to address this gap by evaluating short-term complications of olecranon ORIF using a large, nationwide database to determine complication rates and identify associated risk factors. METHODS: The American College of Surgeons National Surgical Quality Improvement Program database (2010-2023) was queried for patients undergoing olecranon ORIF (Current Procedural Terminology Code 24685). Demographic, comorbidities, operative variables, and postoperative complications within 30 days were analyzed. Descriptive statistics and multivariate logistic regression were used to identify significant predictors (P < .05). RESULTS: A total of 8,524 patients (average age 59.4 ± 19.3; 62.3% female) were included. Surgical site infection was amongst the most common singular complications at a rate of 1.8%, with any adverse event reported at a rate of 7.2%. Risk factors included increased age (odds ratio [OR] = 1.03; P < .001), operative time (OR = 1.02; P < .001), blood transfusion (OR = 3.16; P = .001), ascites, and smoking history. Surgical site infection was associated with smoking (OR = 1.66; P = .01) and ascites (OR = 11.38; P = .03). CONCLUSION: ORIF for olecranon fractures demonstrates low short-term complication rates; however, specific comorbidities such as smoking and ascites were associated with increased risk. These findings highlight opportunities for improving care through providing smoking cessation efforts and tailored perioperative management for high-risk patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。